These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31122084)

  • 1. Changing microRNA Expression during Three-Month Wasp Venom Immunotherapy.
    Specjalski K; Maciejewska A; Pawłowski R; Zieliński M; Trzonkowski P; Pikuła M; Jassem E
    Immunol Invest; 2019 Nov; 48(8):835-843. PubMed ID: 31122084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the Expression of MicroRNA in the Buildup Phase of Wasp Venom Immunotherapy: A Pilot Study.
    Specjalski K; Maciejewska A; Pawłowski R; Chełmińska M; Jassem E
    Int Arch Allergy Immunol; 2016; 170(2):97-100. PubMed ID: 27441833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COMMD8 changes expression during initial phase of wasp venom immunotherapy.
    Kempiński K; Romantowski J; Maciejewska A; Pawłowski R; Chełmińska M; Jassem E; Niedoszytko M
    J Gene Med; 2020 Nov; 22(11):e3243. PubMed ID: 32559011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush immunotherapy for wasp venom allergy seems safe and effective in patients with mastocytosis.
    Verburg M; Oldhoff JM; Klemans RJ; Lahey-de Boer A; de Bruin-Weller MS; Röckmann H; Sanders C; Bruijnzeel-Koomen CA; Pasmans SG; Knulst AC
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):192-6. PubMed ID: 26549336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome survey of insect venom allergic patients with venom immunotherapy in a rural population.
    Roesch A; Boerzsoenyi J; Babilas P; Landthaler M; Szeimies RM
    J Dtsch Dermatol Ges; 2008 Apr; 6(4):292-7. PubMed ID: 18042250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression analysis in predicting the effectiveness of insect venom immunotherapy.
    Niedoszytko M; Bruinenberg M; de Monchy J; Wijmenga C; Platteel M; Jassem E; Oude Elberink JN
    J Allergy Clin Immunol; 2010 May; 125(5):1092-7. PubMed ID: 20334904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of Ultrarush Venom Immunotherapy: Comparison Between Children and Adults.
    Nittner-Marszalska M; Cichocka-Jarosz E; Małaczyńska T; Kraluk B; Rosiek-Biegus M; Kosinska M; Pawłowicz R; Lis G
    J Investig Allergol Clin Immunol; 2016; 26(1):40-7. PubMed ID: 27012015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoblot studies in allergic patients to hymenoptera venom before and during immunotherapy.
    Pereira Santos MC; Pedro E; Spínola Santos A; Branco Ferreira M; Palma Carlos ML; Palma Carlos AG
    Eur Ann Allergy Clin Immunol; 2005 Sep; 37(7):273-8. PubMed ID: 16285233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of specific immunotherapy using an ultra-rush induction regimen in bee and wasp allergy.
    Bożek A; Kołodziejczyk K
    Hum Vaccin Immunother; 2018 Feb; 14(2):288-291. PubMed ID: 29106324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin Test Reactivity to Hymenoptera Venom after Venom Immunotherapy Correlates Inversely with the IgG/IgE Ratio.
    Saulite I; Hoetzenecker W; Guenova E; Schmid-Grendelmeier P; Glatz M
    Int Arch Allergy Immunol; 2017; 174(3-4):190-199. PubMed ID: 29130986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.
    Ewan PW; Deighton J; Wilson AB; Lachmann PJ
    Clin Exp Allergy; 1993 Aug; 23(8):647-60. PubMed ID: 8221268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Limited Long-Term Impact of Insect Venom Immunotherapy on the Micro-RNA Landscape in Whole Blood.
    Karpinski P; Kahraman M; Ludwig N; Skiba P; Kosinska M; Rosiek-Biegus M; Królewicz E; Panaszek B; Nittner-Marszalska M; Blin N; Keller A; Meese E; Sasiadek MM
    J Investig Allergol Clin Immunol; 2019; 29(3):206-212. PubMed ID: 30183661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of a Progressively Prolonged Maintenance Interval of Venom Immunotherapy.
    Kontou-Fili K; Pitsios C; Kompoti E; Giannakopoulos D; Kouridakis S
    Int Arch Allergy Immunol; 2018; 176(1):39-43. PubMed ID: 29649812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three days rush venom immunotherapy in bee allergy: safe, inexpensive and instantaneously effective.
    Goldberg A; Yogev A; Confino-Cohen R
    Int Arch Allergy Immunol; 2011; 156(1):90-8. PubMed ID: 21447964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical study.
    Savi E; Incorvaia C; Boni E; Mauro M; Peveri S; Pravettoni V; Quercia O; Reccardini F; Montagni M; Pessina L; Ridolo E
    PLoS One; 2017; 12(7):e0180270. PubMed ID: 28686638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venom immunotherapy improves health-related quality of life in patients allergic to yellow jacket venom.
    Oude Elberink JN; De Monchy JG; Van Der Heide S; Guyatt GH; Dubois AE
    J Allergy Clin Immunol; 2002 Jul; 110(1):174-82. PubMed ID: 12110838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients still reacting to a sting challenge while receiving conventional Hymenoptera venom immunotherapy are protected by increased venom doses.
    Ruëff F; Wenderoth A; Przybilla B
    J Allergy Clin Immunol; 2001 Dec; 108(6):1027-32. PubMed ID: 11742283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exclusive Bee Venom Allergy: Risk Factors and Outcome of Immunotherapy.
    Rosman Y; Nashef F; Cohen-Engler A; Meir-Shafrir K; Lachover-Roth I; Confino-Cohen R
    Int Arch Allergy Immunol; 2019; 180(2):128-134. PubMed ID: 31216540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrarush venom desensitization after systemic reactions during conventional venom immunotherapy.
    Oren E; Chegini S; Hamilos DL
    Ann Allergy Asthma Immunol; 2006 Nov; 97(5):606-10. PubMed ID: 17165267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.